triple-negative breast cancer

Immunomedics raises $459M as Trodelvy breast cancer launch kicks off amid COVID-19
Immunomedics raises $459M as Trodelvy breast cancer launch kicks off amid COVID-19
Fierce Pharma
Immunomedics
drug launches
Trodelvy
triple-negative breast cancer
pandemic
COVID-19
Flag link:
Back to the drawing board for triple-negative breast cancer targets, researchers propose new combo approach
Back to the drawing board for triple-negative breast cancer targets, researchers propose new combo approach
Endpoints
triple-negative breast cancer
Vanderbilt
R&D
Flag link:
SABCS: Merck's Keytruda notches win in triple-negative breast cancer as Roche's Tecentriq falls short
SABCS: Merck's Keytruda notches win in triple-negative breast cancer as Roche's Tecentriq falls short
Fierce Pharma
Merck
Ketyruda
Roche
Tecentriq
immuno-oncology
SABCS
triple-negative breast cancer
Flag link:
UK gets early access to Roche’s breast cancer immunotherapy
UK gets early access to Roche’s breast cancer immunotherapy
Pharmaforum
Roche
Tecentriq
Celgene
Abraxane
UK
triple-negative breast cancer
Flag link:
Merck drug shrank tumors in some breast cancer patients in trial
Merck drug shrank tumors in some breast cancer patients in trial
Marketwatch
Merck
Keytruda
triple-negative breast cancer
Flag link:
AbbVie Advances with Cancer Candidate
AbbVie Advances with Cancer Candidate
Yahoo/Zacks.com
AbbVie
veliparib
triple-negative breast cancer
Flag link:
AbbVie drug shows promise against difficult type of breast cancer
AbbVie drug shows promise against difficult type of breast cancer
Reuters
AbbVie
veliparib
triple-negative breast cancer
Flag link:
Corcept files IND with FDA for Phase I oncology study
Corcept files IND with FDA for Phase I oncology study
The Fly on the Wall
Corcept Therapeutics
FDA
mifepristone
triple-negative breast cancer
Flag link:
Aveo's Future Depends on Triple-Negative Breast Cancer
Aveo's Future Depends on Triple-Negative Breast Cancer
TheStreet.com
Aveo Oncology
triple-negative breast cancer
tivozanib
Flag link:
EntreMed announces initiation of phase 2 trial in triple-negative breast cancer
EntreMed announces initiation of phase 2 trial in triple-negative breast cancer
Yahoo/Fly on the Wall
EntreMed
triple-negative breast cancer
breast cancer
ENMD-2076
Flag link: